FACULTY SCHOLARSHIP Publications Puneet Kaur (Doctor of Pharmacy Honors class of 2022, Z. Wang lab), Pharmaceutical Sciences Research Associate Jin Gao (Z. Wang lab) and Pharmaceutical Sciences Associate Professor Zhenjia […]
Kennedy Erickson, class of 2023, was sworn in as the American Pharmacists Association – Academy of Student Pharmacists (APhA-ASP) national president during the APhA Annual Meeting and Exposition in San […]
When Belle Wenz first stepped onto the State College of Washington (WSC) campus in the fall of 1918—renamed Washington State University in 1959–the world was in the midst of a […]
Tyler Young grew up in Oakesdale, Washington, a town of about 400 people, and a 45-minute drive south of Spokane. He graduated from high school with only 11 other students in his class and his first job was on the wheat farm where he spent summers from ages 14 to 20 spraying weeds in 90-degree heat, driving a tractor, and harvesting the crop.
A recent $2.2 million gift to Washington State University’s College of Pharmacy and Pharmaceutical Sciences (CPPS) will increase opportunities for PharmD students to focus on the health care needs of residents in rural Washington.
This extraordinary anonymous gift has helped to launch CPPS’ Rural Health Initiative (RHI) to improve access to health care in the rural communities of Washington. Started in the fall of 2021, RHI is an ambitious 10-year plan to create opportunities for student pharmacists and post-graduate pharmacists to specialize in delivery of rural health care. Access to health care providers in rural Washington continues to be a challenge for the nearly 800,000 residents living in these areas. It’s estimated that Washington needs 600 new providers to eliminate this gap in access to care. The Rural Health Initiative aims to alleviate this problem.
From the first days in kindergarten, to the last days of a doctoral program, educators serve a critical role in their students’ lives. They guide students through the curriculum, sharing […]
FACULTY SCHOLARSHIP Publications Pharmaceutical Sciences Associate Professor Sayed Daoud and four co-authors published, “Perturbation of Wnt/b-catenin signaling and sexual dimorphism in non-alcoholic fatty liver disease,” in Hepatol Research, a peer-reviewed […]
Over the month of February, pharmacy student volunteers from the Washington State University College of Pharmacy and Pharmaceutical Sciences spent a few hours each Saturday at the Mobius Discovery Center […]
Pharmacogenomics, a budding field of personalized medicine, is the study of how genes influence an individual’s response to treatment with medications. Drug-related morbidity and mortality due to unoptimized medication therapy is estimated to cost the United States $528 billion annually. According to the Centers for Disease Control and Prevention, adverse drug events (ADEs) have been categorized as a leading cause of preventable death in the United States.